Donald W. DeGolyer's most recent trade in Emergent Biosolutions Inc was a trade of 25,344 Common Stock done . Disclosure was reported to the exchange on April 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 25,344 | 145,202 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Sale of securities on an exchange or to another person at price $ 8.36 per share. | 30 Apr 2026 | 14,527 | 130,675 (0%) | 0% | 8.4 | 121,446 | Common Stock |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 11,296 | 11,296 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Sale of securities on an exchange or to another person at price $ 8.96 per share. | 30 Apr 2026 | 954 | 129,721 (0%) | 0% | 9.0 | 8,548 | Common Stock |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 10 Nov 2025 | 17,801 | 119,858 (0%) | 0% | 10.5 | 187,623 | Common Stock |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Sale of securities on an exchange or to another person at price $ 8.65 per share. | 12 Aug 2025 | 7,844 | 137,659 (0%) | 0% | 8.6 | 67,831 | Common Stock |
| Emergent Biosolutions Inc | DeGolyer W. Donald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 34,403 | 145,503 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Donald DeGolyer W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 15,824 | 41,572 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Sale of securities on an exchange or to another person at price $ 10.91 per share. | 12 Nov 2024 | 25,000 | 111,100 (0%) | 0% | 10.9 | 272,750 | Common Stock |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 25,748 | 25,748 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 17,430 | 136,100 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Donald W. DeGolyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2023 | 118,670 | 118,670 (0%) | 0% | 0 | Common Stock |